Furthermore, restoration of Hoxb13 in SUV-OE AML cells accelerated the leukemia progression and increased the number of LSCs, suggesting Hoxb13 is a downstream effector of Suv39h1 in MA9 leukemia cells. The gene discussed is SUV39H1; the disease is acute myeloid leukemia.